MetLife Investment Management, LLC - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 126 filers reported holding CARIBOU BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$194,498
+47.6%
40,690
+31.2%
0.00%
+100.0%
Q2 2023$131,763
-20.0%
31,0030.0%0.00%0.0%
Q1 2023$164,626
-15.4%
31,0030.0%0.00%
-50.0%
Q4 2022$194,699
-40.5%
31,0030.0%0.00%
-33.3%
Q3 2022$327,082
+94.3%
31,0030.0%0.00%
+200.0%
Q2 2022$168,346
-40.8%
31,0030.0%0.00%
-50.0%
Q1 2022$284,608
+150.4%
31,003
+311.7%
0.00%
+100.0%
Q4 2021$113,643
-36.8%
7,5310.0%0.00%
-50.0%
Q3 2021$179,7657,5310.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q1 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 674,196$6,189,0007.17%
72 Investment Holdings, LLC 474,067$4,352,0004.76%
Velan Capital Investment Management LP 210,695$1,934,0001.80%
PFM Health Sciences, LP 4,370,545$40,122,0001.50%
Monashee Investment Management LLC 470,000$4,315,0001.25%
Avidity Partners Management LP 2,819,067$25,879,0000.54%
Rokos Capital Management LLP 849,334$7,899,0000.37%
Green Alpha Advisors, LLC 49,674$456,0000.31%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 181,304$1,664,0000.25%
Tekla Capital Management LLC 699,377$6,420,0000.22%
View complete list of CARIBOU BIOSCIENCES INC shareholders